Europe Prostate Cancer Epidemiology and Patient Flow Analysis - 2017

Europe Prostate Cancer Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Prostate Cancer patients study in a new report ‘Europe Prostate Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Prostate Cancer epidemiology, Prostate Cancer diagnosed patients, and Prostate Cancer treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Prostate Cancer derived from epidemiological analysis, percentage of patients diagnosed with Prostate Cancer, and percentage of patients treated with a therapy.

The study helps executives estimate Prostate Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Prostate Cancer prevalence, Prostate Cancer diagnosis rate, and Prostate Cancer treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Prostate Cancer Patient Flow
  • Prostate Cancer Prevalence
  • Prostate Cancer Diagnosed Patients
  • Prostate Cancer Treated Patients


1. Prostate Cancer: Disease Definition
2. Prostate Cancer Patient Flow in Europe
2A. Prostate Cancer Prevalence in Europe
2B. Prostate Cancer Diagnosed Patients in Europe
2C. Prostate Cancer Treated Patients in Europe
3. Prostate Cancer Patient Flow in Germany
3A. Prostate Cancer Prevalence in Germany
3B. Prostate Cancer Diagnosed Patients in Germany
3C. Prostate Cancer Treated Patients in Germany
4. Prostate Cancer Patient Flow in France
4A. Prostate Cancer Prevalence in France
4B. Prostate Cancer Diagnosed Patients in France
4C. Prostate Cancer Treated Patients in France
5. Prostate Cancer Patient Flow in Spain
5A. Prostate Cancer Prevalence in Spain
5B. Prostate Cancer Diagnosed Patients in Spain
5C. Prostate Cancer Treated Patients in Spain
6. Prostate Cancer Patient Flow in Italy
6A. Prostate Cancer Prevalence in Italy
6B. Prostate Cancer Diagnosed Patients in Italy
6C. Prostate Cancer Treated Patients in Italy
7. Prostate Cancer Patient Flow in UK
7A. Prostate Cancer Prevalence in UK
7B. Prostate Cancer Diagnosed Patients in UK
7C. Prostate Cancer Treated Patients in UK
8. Research Methodology
List of Tables
Table 1: Prostate Cancer Patient Flow in Europe, 2016
Table 2: Prostate Cancer Patient Flow Forecast in Europe, 2016 - 2025
Table 3: Prostate Cancer Patient Flow in Germany, 2016
Table 4: Prostate Cancer Patient Flow Forecast in Germany, 2016 - 2025
Table 5: Prostate Cancer Patient Flow in France, 2016
Table 6: Prostate Cancer Patient Flow Forecast in France, 2016 - 2025
Table 7: Prostate Cancer Patient Flow in Spain, 2016
Table 8: Prostate Cancer Patient Flow Forecast in Spain, 2016 - 2025
Table 9: Prostate Cancer Patient Flow in Italy, 2016
Table 10: Prostate Cancer Patient Flow Forecast in Italy, 2016 - 2025
Table 11: Prostate Cancer Patient Flow in UK, 2016
Table 12: Prostate Cancer Patient Flow Forecast in UK, 2016 - 2025
List of Figures
Figure 1: Prostate Cancer Patient Flow in Europe, 2016
Figure 2: Prostate Cancer Patient Flow Forecast in Europe, 2016 - 2025
Figure 3: Prostate Cancer Patient Flow in Germany, 2016
Figure 4: Prostate Cancer Patient Flow Forecast in Germany, 2016 - 2025
Figure 5: Prostate Cancer Patient Flow in France, 2016
Figure 6: Prostate Cancer Patient Flow Forecast in France, 2016 - 2025
Figure 7: Prostate Cancer Patient Flow in Spain, 2016
Figure 8: Prostate Cancer Patient Flow Forecast in Spain, 2016 - 2025
Figure 9: Prostate Cancer Patient Flow in Italy, 2016
Figure 10: Prostate Cancer Patient Flow Forecast in Italy, 2016 - 2025
Figure 11: Prostate Cancer Patient Flow in UK, 2016
Figure 12: Prostate Cancer Patient Flow Forecast in UK, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook